4
Changes in Ownership
Lycia Therapeutics, Inc. Filed Acc 0001193125-26-436415
10% owner acquired 7,025,307 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Versant Ventures VII GP, L.P. 10% owner | 2026-10-26 | Conversion | +5,631,425 | 5,631,425 | I | ||
| Versant Ventures VII GP, L.P. 10% owner | 2026-10-26 | Conversion | +1,393,882 | 1,393,882 | I | ||
| Derivatives | |||||||
| Versant Ventures VII GP, L.P. 10% owner | 2026-10-26 | Conversion · Series A Preferred Stock | −25,390,410 | 0 | I | ||
| Versant Ventures VII GP, L.P. 10% owner | 2026-10-26 | Conversion · Series B Preferred Stock | −6,284,597 | 0 | I | ||
Loading xslF345X06/ownership.xml…